trial · primary record
Tenecteplase (rhTNK-tPA) (0.25 mg/kg, to maximum of 25mg)
Acute Ischemic Stroke
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1266 |
| Primary completion | 2030-03-01 |
| Primary endpoint | Functional Independence at 90 Days |
| Registry ID | NCT07912970 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:59:03.979Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07912970
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.